A randomised clinical trial investigating the effect of fondaparinux versus enoxaparin in acute medically ill, non-surgical patients
Studied treatment | fondaparinux 2.5mg qd |
Control treatment | enoxaparin 40mg qd |
Patients | acute medically ill, non-surgical patients |
Group sizes | -9 / -9 |
DVT diagnosis | |
PE diagnosis |
Blindness | Inclusion period | ||
Follow-up duration | Centers | single center | |
Lost to FU | geographical localisation | Germany | |
Primary endpoint | Design | Parallel groups |
ClinicalTrial.gov record NCT00521885
Appears in following systematic reviews: